Riitta Lassila

6.6k total citations
213 papers, 4.7k citations indexed

About

Riitta Lassila is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Riitta Lassila has authored 213 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Hematology, 72 papers in Cardiology and Cardiovascular Medicine and 58 papers in Internal Medicine. Recurrent topics in Riitta Lassila's work include Venous Thromboembolism Diagnosis and Management (58 papers), Platelet Disorders and Treatments (55 papers) and Blood Coagulation and Thrombosis Mechanisms (44 papers). Riitta Lassila is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (58 papers), Platelet Disorders and Treatments (55 papers) and Blood Coagulation and Thrombosis Mechanisms (44 papers). Riitta Lassila collaborates with scholars based in Finland, United States and Sweden. Riitta Lassila's co-authors include Mauri Lepäntalo, Lotta Joutsi‐Korhonen, Pia Siljander, Seija Peltonen, Olli Carpén, Petri T. Kovanen, Petteri Kauhanen, Seppo Juvela, Pirjo Mustonen and Annukka Jouppila and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Riitta Lassila

202 papers receiving 4.6k citations

Peers

Countries citing papers authored by Riitta Lassila

Since Specialization

Citations

This map shows the geographic impact of Riitta Lassila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riitta Lassila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riitta Lassila more than expected).

Fields of papers citing papers by Riitta Lassila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riitta Lassila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riitta Lassila. The network helps show where Riitta Lassila may publish in the future.

Co-authorship network of co-authors of Riitta Lassila

This figure shows the co-authorship network connecting the top 25 collaborators of Riitta Lassila. A scholar is included among the top collaborators of Riitta Lassila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riitta Lassila. Riitta Lassila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health‐Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study 2025 ·Haemophilia ·Jan Astermark, Susanna Ranta, (unknown), (unknown), Stéphane Quéré, (unknown), Susan Robson, (unknown), Riitta Lassila, Pål André Holme	0
2	Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update 2025 ·Haemophilia ·Carmen Escuriola Ettingshausen, Riitta Lassila, Ginés Escolar, Christoph Male, Kathrin Schirner, (unknown), Erik Berntorp	4
3	Advances in Von Willebrand Disease 2025 ·Haemophilia ·Riitta Lassila, Ferdows Atiq, Caterina Casari, Michelle Lavin	0
4	Venous thromboembolism incidence and association with overall survival in pancreatic cancer: A Finnish nationwide cohort study 2024 ·Cancer Medicine ·(unknown), Harri Mustonen, Pauli Puolakkainen, Caj Haglund, Katriina Peltola, Olli Carpén, Riitta Lassila, Hanna Seppänen	1
5	Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A 2024 ·Haemophilia ·Pål André Holme, Jan Blatný, (unknown), Riitta Lassila, Niamh O’Connell, Cédric Hermans, María Román, Claude Négrier, Antonio Coppola, Johannes Oldenburg	3
6	Development of a Coagulation Disorders Unit 2024 ·Seminars in Thrombosis and Hemostasis ·Tímea Szántó, (unknown), Lotta Joutsi‐Korhonen, (unknown), (unknown), (unknown), Riitta Lassila	1
7	Role of red blood cells in clinically relevant bleeding tendencies and complications 2023 ·Journal of Thrombosis and Haemostasis ·Riitta Lassila, John W. Weisel	17
8	No difference in quality of life between persons with severe haemophilia A and B 2023 ·Haemophilia ·(unknown), Fariba Baghaei, Maria Bruzelius, (unknown), Pål André Holme, Riitta Lassila, (unknown), Susanna Ranta, Nadine G. Andersson, Erik Berntorp, Jan Astermark	4
9	Factor IX antibodies and tolerance in hemophilia B in the Nordic countries – The impact of F9 variants and complications 2022 ·Thrombosis Research ·(unknown), Fariba Baghaei, Maria Bruzelius, (unknown), Pål André Holme, Riitta Lassila, Myriam Martin, (unknown), Susanna Ranta, Karin Strandberg, Nadine G. Andersson, Erik Berntorp, Jan Astermark	1
10	Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer 2022 ·Cancer Medicine ·(unknown), Harri Mustonen, (unknown), Riitta Lassila, Caj Haglund, Hanna Seppänen	9
11	Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial 2022 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), Kaisu Luiro, Tímea Szántó, (unknown), Leena Hiltunen, Susanna Sainio, Terhi Piltonen, Riitta Lassila, Juha S. Tapanainen, Oskari Heikinheimo	11
12	Characterisation of healthcare utilisation and cost of haemophilia care in real‐life: A 4‐year follow‐up study in Finland 2020 ·Haemophilia ·(unknown), (unknown), Jari Jokelainen, Timo Siitonen, (unknown), Outi Laine, (unknown), (unknown), (unknown), Anu Partanen, Miika Linna, Tero Ylisaukko‐oja, Riitta Lassila	0
13	Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub‐study of the ENOKSI thromboprophylaxis RCT 2020 ·Acta Anaesthesiologica Scandinavica ·Annukka Vahtera, Tímea Szántó, Riitta Lassila, Miia Valkonen, (unknown), Heini Huhtala, Ville Pettilä, Anne Kuitunen	3
14	Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study 2019 ·Haemophilia ·(unknown), Karin Strandberg, Erik Berntorp, Roza Chaireti, Pål André Holme, Ole H. Larsen, Riitta Lassila, Annukka Jouppila, Tímea Szántó, Eva Zetterberg	13
15	Phenotypic characterization of haemophilia B – Understanding the underlying biology of coagulation factor IX 2019 ·Haemophilia ·Anna Tjärnlund‐Wolf, Riitta Lassila	13
16	Cellular Factor XIII, a Transglutaminase in Human Corneal Keratocytes 2019 ·International Journal of Molecular Sciences ·Zsuzsanna Orosz, Helga Bárdos, Amir H. Shemirani, Ildikó Beke Debreceni, Riitta Lassila, (unknown), Johanna A. Kremer Hovinga, Theo Seiler, (unknown), Verena Schroeder, Z Boda, László Nemes, (unknown), Bence Nagy, Andrea Facskó, János Kappelmayer, László Muszbek	6
17	Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD – A longitudinal study 2017 ·PLoS ONE ·Beata Przybyla, (unknown), Jari Petäjä, Lotta Joutsi‐Korhonen, Karin Strandberg, Andreas Hillarp, (unknown), Tapani Ruutu, Liisa Volin, Riitta Lassila	4
18	Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data 2007 ·Haemophilia ·Michael Richards, Carmen Altisent, Angelika Bátorová, Hérvè Chambost, G. Dolan, Philippe de Moerloose, Máximo Fraga, Cédric Hermans, Anastasia Karafoulidou, Robert Klamroth, Riitta Lassila, C. Rothschild, (unknown)	54
19	Association of the Fibrinolytic System and Hemorheology with Symptoms in Patients with Carotid Occlusive Disease 2005 ·Cerebrovascular Diseases ·Lauri Soinne, Eija Saimanen, (unknown), Petri T. Kovanen, Perttu J. Lindsberg, Markku Kaste, Riitta Lassila	11
20	Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation 1998 ·Journal of Thrombosis and Haemostasis ·Ulla Wartiovaara, Petri Salvén, Hanna Mikkola, Riitta Lassila, Jaakko Kaukonen, Vladimir Joukov, Arto Orpana, Ari Ristimäki, Markku Heikinheimo, Heikki Joensuu, Kari Alitalo, Aarno Palotie	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact